Cargando…

Nanomedicine and graphene-based materials: advanced technologies for potential treatments of diseases in the developing nervous system

ABSTRACT: The interest in graphene-based nanomaterials (GBNs) application in nanomedicine, in particular in neurology, steadily increased in the last decades. GBNs peculiar physical–chemical properties allow the design of innovative therapeutic tools able to manipulate biological structures with sub...

Descripción completa

Detalles Bibliográficos
Autores principales: Cellot, Giada, Franceschi Biagioni, Audrey, Ballerini, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411050/
https://www.ncbi.nlm.nih.gov/pubmed/34480086
http://dx.doi.org/10.1038/s41390-021-01681-6
_version_ 1784775234043248640
author Cellot, Giada
Franceschi Biagioni, Audrey
Ballerini, Laura
author_facet Cellot, Giada
Franceschi Biagioni, Audrey
Ballerini, Laura
author_sort Cellot, Giada
collection PubMed
description ABSTRACT: The interest in graphene-based nanomaterials (GBNs) application in nanomedicine, in particular in neurology, steadily increased in the last decades. GBNs peculiar physical–chemical properties allow the design of innovative therapeutic tools able to manipulate biological structures with subcellular resolution. In this review, we report GBNs applications to the central nervous system (CNS) when these nanomaterials are engineered as potential therapeutics to treat brain pathologies, with a focus on those of the pediatric age. We revise the state-of-the art studies addressing the impact of GBNs in the CNS, showing that the design of GBNs with different dimensions and chemical compositions or the use of specific administration routes and doses can limit unwanted side effects, exploiting GBNs efficacy in therapeutic approaches. These features favor the development of GBNs-based multifunctional devices that may find applications in the field of precision medicine for the treatment of disorders in the developing CNS. In this framework, we address the suitability of GBNs to become successful therapeutic tools, such as drug nano-delivery vectors when being chemically decorated with pharmaceutical agents and/or other molecules to obtain a high specific targeting of the diseased area and to achieve a controlled release of active molecules. IMPACT: The translational potential of graphene-based nanomaterials (GBNs) can be used for the design of novel therapeutic approaches to treat pathologies affecting the brain with a focus on the pediatric age. GBNs can be chemically decorated with pharmaceutical agents and molecules to obtain a highly specific targeting of the diseased site and a controlled drug release. The type of GBNs, the selected functionalization, the dose, and the way of administration are factors that should be considered to potentiate the therapeutic efficacy of GBNs, limiting possible side effects. GBNs-based multifunctional devices might find applications in the precision medicine and theranostics fields.
format Online
Article
Text
id pubmed-9411050
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group US
record_format MEDLINE/PubMed
spelling pubmed-94110502022-08-27 Nanomedicine and graphene-based materials: advanced technologies for potential treatments of diseases in the developing nervous system Cellot, Giada Franceschi Biagioni, Audrey Ballerini, Laura Pediatr Res Review Article ABSTRACT: The interest in graphene-based nanomaterials (GBNs) application in nanomedicine, in particular in neurology, steadily increased in the last decades. GBNs peculiar physical–chemical properties allow the design of innovative therapeutic tools able to manipulate biological structures with subcellular resolution. In this review, we report GBNs applications to the central nervous system (CNS) when these nanomaterials are engineered as potential therapeutics to treat brain pathologies, with a focus on those of the pediatric age. We revise the state-of-the art studies addressing the impact of GBNs in the CNS, showing that the design of GBNs with different dimensions and chemical compositions or the use of specific administration routes and doses can limit unwanted side effects, exploiting GBNs efficacy in therapeutic approaches. These features favor the development of GBNs-based multifunctional devices that may find applications in the field of precision medicine for the treatment of disorders in the developing CNS. In this framework, we address the suitability of GBNs to become successful therapeutic tools, such as drug nano-delivery vectors when being chemically decorated with pharmaceutical agents and/or other molecules to obtain a high specific targeting of the diseased area and to achieve a controlled release of active molecules. IMPACT: The translational potential of graphene-based nanomaterials (GBNs) can be used for the design of novel therapeutic approaches to treat pathologies affecting the brain with a focus on the pediatric age. GBNs can be chemically decorated with pharmaceutical agents and molecules to obtain a highly specific targeting of the diseased site and a controlled drug release. The type of GBNs, the selected functionalization, the dose, and the way of administration are factors that should be considered to potentiate the therapeutic efficacy of GBNs, limiting possible side effects. GBNs-based multifunctional devices might find applications in the precision medicine and theranostics fields. Nature Publishing Group US 2021-09-03 2022 /pmc/articles/PMC9411050/ /pubmed/34480086 http://dx.doi.org/10.1038/s41390-021-01681-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Review Article
Cellot, Giada
Franceschi Biagioni, Audrey
Ballerini, Laura
Nanomedicine and graphene-based materials: advanced technologies for potential treatments of diseases in the developing nervous system
title Nanomedicine and graphene-based materials: advanced technologies for potential treatments of diseases in the developing nervous system
title_full Nanomedicine and graphene-based materials: advanced technologies for potential treatments of diseases in the developing nervous system
title_fullStr Nanomedicine and graphene-based materials: advanced technologies for potential treatments of diseases in the developing nervous system
title_full_unstemmed Nanomedicine and graphene-based materials: advanced technologies for potential treatments of diseases in the developing nervous system
title_short Nanomedicine and graphene-based materials: advanced technologies for potential treatments of diseases in the developing nervous system
title_sort nanomedicine and graphene-based materials: advanced technologies for potential treatments of diseases in the developing nervous system
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411050/
https://www.ncbi.nlm.nih.gov/pubmed/34480086
http://dx.doi.org/10.1038/s41390-021-01681-6
work_keys_str_mv AT cellotgiada nanomedicineandgraphenebasedmaterialsadvancedtechnologiesforpotentialtreatmentsofdiseasesinthedevelopingnervoussystem
AT franceschibiagioniaudrey nanomedicineandgraphenebasedmaterialsadvancedtechnologiesforpotentialtreatmentsofdiseasesinthedevelopingnervoussystem
AT ballerinilaura nanomedicineandgraphenebasedmaterialsadvancedtechnologiesforpotentialtreatmentsofdiseasesinthedevelopingnervoussystem